Proteomic analysis of cancer-cell mitochondria

Nature Reviews Cancer

Volumn 3, Issue 10, 2003, Pages 789-795

  Verma, Mukesh ^a   Kagan, Jacob ^a   Sidransky, David ^b   Srivastava, Sudhir ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

AGING; CANCER CELL; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CELL COMPARTMENTALIZATION; DATA ANALYSIS; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPLICATION; EARLY DIAGNOSIS; ENCEPHALOMYOPATHY; GENE EXPRESSION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL GENETICS; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; PHENOTYPE; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS; REVIEW; RISK ASSESSMENT; THREE DIMENSIONAL IMAGING; GENETICS; HUMAN; NEOPLASM; PATHOLOGY;

HUMANS; MITOCHONDRIA; NEOPLASMS; PROTEOMICS;

EID: 0142197219     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1192     Document Type: Review

References (41)

1. Fliss, M. S. et al. Facile detection of mitochondrial mutations in tumours and body fluids. Science 287, 2017-2019 (2000).
2. Costantini, P., Jacotot, E., Decaudin, D. & Kroemer, G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl Cancer Inst. 92, 1042-1053 (2000).
3. Kroegmer, G. Mitochondrial control of aopotosis. Biochem. Soc. Symp. 66, 1-15 (1999).
4. Thress, K., Kornbluth, S. & Smith, J. J. Mitochondria at the crossroad of apoptotic cell death. Mitochondria at the crossroad of apoptotic cell death. J. Bioenerg. Biomembr. 31, 321-326 (1999).
5. Fernandez, M. G. et al. Early changes in intramitochondrial cardiolipin distribution during apoptosis. Cell Growth Differ. 13, 449-455 (2002).
6. Alonso, A. et al. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophotesis 18, 682-685 (1997).
7. Anderson, L. & Seilamer, J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533-537 (1997).
8. Jeronimo, C. et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20, 5195-5198 (2001).
9. Jones, J. B. et al. Detection of mitochondrial DNA mutations in pancreatic cancer offers a 'mass'-ive advantage over detection of nuclear DNA mutations. Cancer Res. 61, 1299-1304 (2001).
10. Copeland, W., Waschman, J., Johnson, J. & Penta, J. Mitochondrial DNA alterations in cancer. Cancer Invest. 20, 557-569 (2002).
11. Ha, P. K. et al. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin. Cancer Res. 8, 2260-2265 (2002).
12. Sanchez-Cespedes et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 61, 7015-7019 (2001).
13. Parrella, P. et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 61, 7623-7626 (2001).
14. Nomoto, S., Yamashita, K., Koshikawa, K., Nakao, A. & Sidransky, D. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin. Cancer Res. 8, 481-487 (2002).
15. Eng, C. Kiuru, M., Fernandez, M. J. & Aaltonen, L. A. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nature Rev. Cancer 3, 193-202 (2003).
16. Lopez, M. F. & Melov, S. Applied proteomics: mitochondrial proteins and effect on function. Circ. Res. 90, 380-389 (2002).
17. Tan, D. J. et al. Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers. Genes Chromosom. Cancer 37, 186-194 (2003).
18. Murray, J., Gilkerson, R. & Capaldi, R. A. Quantitative proteomics: the copy number of pyruvate dehydrogenase is more than 102 fold lower than that of complex III in human mitochondria. FEBS Lett. 529, 173-178 (2002).
19. Petricoin, E. F. & Liotta, L. A. Mass spectrometry based diagnostics: the upcoming revolution in disease detection. Clin. Chem. 49, 533-534 (2003).
20. Vissers, J. P., Blackburn, R. K., & Moseley, M. A. A novel interface for variable nanoscale LC/MS for improved proteome coverage. J. Am. Soc. Mass Spectrom. 13, 760-771 (2002).
21. Brookes, P. S. et al. High-throughput two-dimensional blue-native electrophoresis: a tool for functional proteomics of mitochondria and signaling complexes. Proteomics 2, 969-977 (2002).
22. Tryoen-Toth P. et al. Proteomic consequences of a human mitochondrial tRNA mutation beyond the frame of mitochondrial translation. J. Biol. Chem. 278, 24314-24323 (2003).
23. Anderson, N. L. & Anderson, N. G. Proteome and proteomics: new technologies, new concepts and new words. Electrophoresis 19, 1853-1861 (1998).
24. Gygi, S. P., Rochon, Y., Franza, B. B. & Aebersold, R. Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 19, 1720-1730 (1999).
25. Zhou, G. et al. 2D Differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics 1, 117-123 (2002).
26. Wall, D. B. et al. Three-dimensional protein map according to pl, hydophobicity and molecular mass. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 774, 53-58 (2002).
27. Merchant, M. & Weinberger, S. R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21, 1164-1177 (2000).
28. Fung, E. T. & Enderwick, C. ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques 34, 40-41 (2002).
29. Lin, T. K. et al. Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach. J. Biol. Chem. 277, 17048-17056 (2002).
30. Yu, W. et al. RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 63, 2483-2491 (2003).
31. Lopez, M. F. et al. High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis 21, 3427-3440 (2000).
32. Rabilloud, T. et al. Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis 19, 1006-1014 (1998).
33. SidransKy, D. Emerging molecular markers of cancer. Nature Rev. Cancer 2, 210-219 (2002).
34. Wallace, D. C. Mitochondrial diseases in man and mouse. Science 283, 1482-1488 (1999).
35. Tong, B. C. et al. Mitochondrial DNA alterations in thyroid cancer. J. Surg. Oncol. 82, 170-173 (2003).
36. Mambo, E. et al. Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc. Natl Acad. Sci. USA 100, 1838-1843 (2003).
37. Hirano, M. et al. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin. Cell Dev. Biol. 12, 417-427 (2001).
38. Kaukonen, J. et al. A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophthalmoplegia. Am. J. Hum. Genet. 65, 256-261 (1999).
39. Mitsumoto, A., Takeuchi, A., Okawa, K. & Nakagawa, Y. A subset of newly synthesized polypeptides in mitochondria from human endothelial cells exposed to hydroperoxide stress. Free Radic. Biol. Med. 32, 22-37 (2002).
40. Scheffler, I. E. Mitochondria make a come back. Adv. Drug. Deliv. Rev. 49, 3-26 (2001).
41. Rabilloud, T. et al. The mitochondrial antioxidant defence system and its response to oxidative stress. Proteomics 1, 1105-1110 (2001).